60
Views
2
CrossRef citations to date
0
Altmetric
Review

Trigeminal–autonomic headaches in daily clinical practice

&
Pages 1531-1543 | Published online: 10 Jan 2014

References

  • Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia24(Suppl. 1), 1–160 (2004).
  • Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain120(Pt 1), 193–209 (1997).
  • Matharu MS, Cohen AS, McGonigle DJ, Ward N, Frackowiak RS, Goadsby PJ. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache44(8), 747–761 (2004).
  • Olesen J, Tfelt-Hansen P, Welch K. The Headaches. Lippincott Williams & Wilkins, PA, USA (1999).
  • Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for disorders, cranial neuralgias and facial pain. Cephalalgia8(7), 1–96 (1988).
  • Isler H. Episodic cluster headache from a textbook of: Van Swieten’s classic description (1745). Cephalalgia1(3), 172–174 (1993)
  • Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol.1(4), 251–257 (2002).
  • Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain117(Pt 3), 427–434 (1994).
  • Kunkle EC, Pfieffer J, Wilhoit WM, Hamrick J. Recurrent brief headache in cluster pattern. Trans. Am. Neurol. Assoc. 56(77th Meeting), 240–243 (1952).
  • Ekbom K. Nitroglycerin as a provocative agent in cluster headache. Arch. Neurol.19(5), 487–493 (1968).
  • Ekbom K. Patterns of cluster headache with a note on the relations to angina pectoris and peptide ulcer. Acta Neurol. Scand.46(2), 225–237 (1970).
  • Kudrow L. The cylic relationship of natural illumination to cluster period frequency. Cephalalgia7(6), 76–78 (1987).
  • Strittmatter M, Hamann GF, Grauer M et al. Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache. Neuroreport7(7), 1229–1234 (1996).
  • Leone M, Patruno G, Vescovi A, Bussone G. Neuroendocrine dysfunction in cluster headache. Cephalalgia10(5), 235–239 (1990).
  • Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J. Neurol. Neurosurg. Psychiatry50(2), 207–213 (1987).
  • May A, Ashburner J, Buchel C et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat. Med.5(7), 836–838 (1999).
  • Sprenger T, Boecker H, Tolle TR, Bussone G, May A, Leone M. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology62(3), 516–517 (2004).
  • May A, Bahra A, Buchel C, Turner R, Goadsby PJ. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann. Neurol.6(5), 791–794 (1999).
  • Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle TR. SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain113(3), 422–426 (2005).
  • Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann. Neurol.59(3), 535–545 (2006).
  • Matharu MS, Good CD, May A, Bahra A, Goadsby PJ. No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur. J. Neurol.10(1), 53–57 (2003).
  • Schmidt-Wilcke T, Leinisch E, Straube A et al. Gray matter decrease in patients with chronic tension type headache. Neurology65(9), 1483–1486 (2005).
  • May A, Kaube H, Büchel C et al. Experimental cranial pain elicited by capsaicin: a PET-study. Pain74(1), 61–66 (1998).
  • Cohen AS, Matharu MS, Kalisch R, Friston K, Goadsby PJ. Functional MRI in SUNCT shows differential hypothalamic activation with increasing pain. Cephalalgia24, 1098–1099 (2004).
  • Sprenger T, Valet M, Hammes M et al. Hypothalamic activation in trigeminal autonomic cephalgia: functional imaging of an atypical case. Cephalalgia24(9), 753–757 (2004).
  • May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet366(9488), 843–855 (2005).
  • Cluster Headache Syndrome. Sjaastad O (Ed.). WB Saunders Company Ltd, London, UK (1992).
  • Manzoni GC, Micieli G, Granella F, Tassorelli C, Zanferrari C, Cavallini A. Cluster headache – course over ten years in 189 patients. Cephalalgia11(4), 169–174 (1991).
  • Waldenlind E, Drummond PD. Synthesis of cluster headache pathophysiology in: The Headaches. Olesen J, Tfelt Hansen P, Welch KM (Eds). Lippincott Williams & Wilkins, PA, USA (1999).
  • Leone M, Attanasio A, Croci D et al. Neuroendocrinology of cluster headache. Ital. J. Neurol. Sci.20(7), S18–S20 (1999).
  • Manzoni GC. Cluster headache and lifestyle: remarks on a population of 374 male patients. Cephalalgia19(2), 88–94 (1999).
  • Kudrow L. Natural history of cluster headache. Part I. Outcome of drop-out patients. Headache22(5), 203–206 (1982).
  • Sjaastad O, Dale I. Evidence for a new (?), treatable headache entity. Headache14(2), 105–108 (1974).
  • Dodick DW. Indomethacin-responsive headache syndromes. Curr. Pain. Headache Rep.8(1), 19–26 (2004).
  • Sjaastad O, Apfelbaum R, Caskey W et al. Chronic paroxysmal hemicrania (CPH). The clinical manifestations. A review. Ups. J. Med. Sci.31(Suppl.), 27–33 (1980).
  • Sandrini G, Friberg L, Janig W et al. Neurophysiological tests and neuroimaging procedures in non-acute headache: guidelines and recommendations. Eur. J. Neurol.11(4), 217–224 (2004).
  • Dodick D, Rozen T, Goadsby P, Silberstein S. Cluster headache. Cephalalgia20(9), 787–803 (2000).
  • May A. Headaches with (ipsilateral) autonomic symptoms. J. Neurol.250(11), 1273–1278 (2003).
  • Nilsson Remahl AI, Laudon Meyer E, Cordonnier C, Goadsby PJ. Placebo response in cluster headache trials: a review. Cephalalgia23(7), 504–510 (2003).
  • Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs63(16), 1637–1677 (2003).
  • May A, Leone M. Update on cluster headache. Curr. Opin. Neurol.16(3), 333–340 (2003).
  • Leone M. Chronic cluster headache: new and emerging treatment options. Curr. Pain. Headache Rep.8(5), 347–352 (2004).
  • The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N. Engl. J. Med.325(5), 322–326 (1991).
  • Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group.Acta Neurol. Scand.88(1), 63–69 (1993).
  • Stovner LJ, Sjaastad O. Treatment of cluster headache and its variants. Curr. Opin. Neurol.8(3), 243–247 (1995).
  • Wilkinson M, Pfaffenrath V, Schoenen J, Diener HC, Steiner TJ. Migraine and cluster headache – their management with sumatriptan: a critical review of the current clinical experience. Cephalalgia15(5), 337–357 (1995).
  • Ekbom K, Krabbe A, Micelli G et al. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Cephalalgia15(3), 230–236 (1995).
  • Göbel H, Lindner V, Heinze A, Ribbat M, Deuschl G. Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology51(3), 908–911 (1998).
  • Schuh-Hofer S, Reuter U, Kinze S, Einhaupl KM, Arnold G. Treatment of acute cluster headache with 20 mg sumatriptan nasal spray – an open pilot study. J. Neurol.249(1), 94–99 (2002).
  • Van Vliet JA, Bahra A, Martin V et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology60(4), 630–633 (2003).
  • Bahra A, Gawel MJ, Hardebo JE et al. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology54(9), 1832–1839 (2000).
  • Pascual J, Navarro A, Caminero AB, Jurado C. Experience with intranasal zolmitriptan in cluster headache. Neurologia21(3), 131–134 (2006).
  • Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby P. Effectiveness of Intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch. Neurol. (2006) (Epub ahead of print).
  • Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache21(1), 1–4 (1981).
  • Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch. Neurol.42(4), 362–363 (1985).
  • Robbins L. Intranasal lidocaine for cluster headache. Headache35(2), 83–84 (1995).
  • Mills TM, Scoggin JA. Intranasal lidocaine for migraine and cluster headaches. Ann. Pharmacother.31(7–8), 914–915 (1997).
  • Markley HG. Topical agents in the treatment of cluster headache. Curr. Pain. Headache Rep.7(2), 139–143 (2003).
  • Horton B, Ryan R, Reynolds J. Clinical observations of the use of E.C. 110, a new agent for the treatment of headache. Mayo Clin. Proc.23, 104–108 (1948).
  • Friedman AP, Mikropoulos HE. Cluster headaches. Neurology8(9), 653–663 (1958).
  • Graham JR, Malvea BP, Gramm HF. Aerosol ergotamine tartrate for migraine and Horton’s syndrome. N. Engl. J. Med.263, 802–804 (1960).
  • Ekbom K, Krabbe AE, Paalzow G, Paalzow L, Tfelt-Hansen P, Waldenlind E. Optimal routes of administration of ergotamine tartrate in cluster headache patients. A pharmacokinetic study. Cephalalgia3(1), 15–20 (1983).
  • Mather PJ, Silberstein SD, Schulman EA, Hopkins MM. The treatment of cluster headache with repetitive intravenous dihydroergotamine. Headache31(8), 525–532 (1991).
  • Magnoux E, Zlotnik G. Outpatient intravenous dihydroergotamine for refractory cluster headache. Headache44(3), 249–255 (2004).
  • Sicuteri F, Geppetti P, Marabini S, Lembeck F. Pain relief by somatostatin in attacks of cluster headache. Pain18(4), 359–365 (1984).
  • Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann. Neurol.56(4), 488–494 (2004).
  • May A, Leone M, Áfra J et al. EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur. J. Neurol.13(6), 560–572 (2006).
  • Ekbom K, Hardebo JE. Cluster headache: aetiology, diagnosis and management. Drugs62(1), 61–69 (2002).
  • Matharu MS, van Vliet JA, Ferrari MD, Goadsby PJ. Verapamil induced gingival enlargement in cluster headache. J. Neurol. Neurosurg. Psychiatry76(1), 124–127 (2005).
  • Ekbom K. Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache21(4), 132–139 (1981).
  • Manzoni GC, Bono G, Lanfranchi M, Micieli G, Terzano MG, Nappi G. Lithium carbonate in cluster headache: assessment of its short- and long-term therapeutic efficacy. Cephalalgia3(2), 109–114 (1983).
  • Curran D, Hinterberger H, Lance J. Methysergide. Research and clinical studies. Headache1, 74–122 (1967).
  • Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr. Pain. Headache Rep.5(1), 83–91 (2001).
  • McGeeney BE. Topiramate in the treatment of cluster headache. Curr. Pain. Headache Rep.7(2), 135–138 (2003).
  • Forderreuther S, Mayer M, Straube A. Treatment of cluster headache with topiramate: effects and side-effects in five patients. Cephalalgia22(3), 186–189 (2002).
  • Rozen TD. Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia. Headache41(Suppl. 1), 25–33 (2001).
  • Leone M, Dodick D, Rigamonti A et al. Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia23(10), 1001–1002 (2003).
  • Ekbom K. Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta Neurol. Scand.45(5), 601–610 (1969).
  • Speight TM, Avery GS. Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs3(3), 159–203 (1972).
  • Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia16(7), 494–496 (1996).
  • Pringsheim T, Magnoux E, Dobson CF, Hamel E, Aube M. Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study. Headache42(8), 787–792 (2002).
  • Gallagher RM, Mueller LL, Freitag FG. Divalproex sodium in the treatment of migraine and cluster headaches. J. Am. Osteopath. Assoc.102(2), 92–94 (2002).
  • Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia9(3), 195–198 (1989)
  • El Amrani M, Massiou H, Bousser MG. A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia22(3), 205–208 (2002).
  • Marks DR, Rapoport A, Padla D et al. A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache. Cephalalgia13(2), 114–116 (1993).
  • Sicuteri F, Fusco BM, Marabini S et al. Beneficial effect of capsaicin application to the nasal mucosa in cluster headache. Clin. J. Pain5(1), 49–53 (1989).
  • Fusco BM, Marabini S, Maggi CA, Fiore G, Geppetti P. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain59(3), 321–325 (1994).
  • Ahmed F. Chronic cluster headache responding to gabapentin: a case report. Cephalalgia20(4), 252–253 (2000).
  • Tay BA, Ngan Kee WD, Chung DC. Gabapentin for the treatment and prophylaxis of cluster headache. Reg. Anesth. Pain Med.26(4), 373–375 (2001).
  • Siow HC, Pozo-Rosich P, Silberstein SD. Frovatriptan for the treatment of cluster headaches. Cephalalgia24(12), 1045–1048 (2004).
  • Eekers PJ, Koehler PJ. Naratriptan prophylactic treatment in cluster headache. Cephalalgia21(1), 75–76 (2001).
  • Mulder LJ, Spierings EL. Naratriptan in the preventive treatment of cluster headache. Cephalalgia22(10), 815–817 (2002).
  • Loder E. Naratriptan in the prophylaxis of cluster headache. Headache42(1), 56–57 (2002).
  • Zebenholzer K, Wober C, Vigl M, Wessely P. Eletriptan for the short-term prophylaxis of cluster headache. Headache44(4), 361–364 (2004).
  • Monstad I, Krabbe A, Micieli G et al. Preemptive oral treatment with sumatriptan during a cluster period. Headache35(10), 607–613 (1995).
  • Ekbom K. Ergotamine tartrate orally in Horton’s histaminic Cephalalgia (also called Harris’s ciliary neuralgia). Acta Psychiatr. Scand.46, 106 (1947).
  • Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes – prolonged effects from a single injection. Pain122(1–2), 126–129 (2006).
  • Ambrosini A, Vandenheede M, Rossi P et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain118(1–2), 92–96 (2005).
  • Scattoni L, Di Stani F, Villani V et al. Great occipital nerve blockade for cluster headache in the emergency department: case report. J. Headache Pain7(2), 98–100 (2006).
  • Anthony M. Arrest of attacks of cluster headache by local steroid injection of the occipital nerve. In: Migraine. Rose C (Ed.). Karger, Basel, Switzerland, 169–173 (1985).
  • Peres MF, Stiles MA, Siow HC, Rozen TD, Young WB, Silberstein SD. Greater occipital nerve blockade for cluster headache. Cephalalgia22(7), 520–522 (2002).
  • Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain125(Pt 5), 976–984 (2002).
  • Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N. Engl. J. Med.345(19), 1428–1429 (2001).
  • Franzini A, Ferroli P, Leone M, Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery52(5), 1095–1101 (2003).
  • Leone M, Franzini A, Broggi G, May A, Bussone G. Long-term follow-up of bilateral hypothalamic stimulation for intractable cluster headache. Brain127(Pt 10), 2259–2264 (2004).
  • Schoenen J, Di Clemente L, Vandenheede M et al. Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain128(Pt 4), 940–947 (2005).
  • May A, Leone M, Boecker H, Sprenger T et al. Hypothalamic deep brain stimulation in PET. J. Neurosci.26(13), 3589–3593 (2006).
  • Leone M, May A, Franzini A et al. Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia24(11), 934–937 (2004).
  • Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain127(Pt 1), 220–230 (2004).
  • Schwedt TJ, Dodick DW, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic cluster headache and hemicrania continua: pain relief and persistence of autonomic features. Cephalalgia26(8), 1025–1027 (2006).
  • Sjaastad O, Stovner LJ, Stolt Nielsen A, Antonaci F, Fredriksen TA. CPH and hemicrania continua: requirements of high indomethacin dosages – an ominous sign? Headache35(6), 363–367 (1995).
  • Boes CJ, Dodick DW. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache42(8), 699–708 (2002).
  • Evers S, Husstedt IW. Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache36(7), 429–432 (1996).
  • Matharu MS, Cohen AS, Boes CJ, Goadsby PJ. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review. Curr. Pain. Headache Rep.7(4), 308–318 (2003).
  • Pareja JA, Caminero AB, Sjaastad O. SUNCT Syndrome: diagnosis and treatment. CNS Drugs16(6), 373–383 (2002).
  • Hunt CH, Dodick DW, Bosch EP. SUNCT responsive to gabapentin. Headache42(6), 525–526 (2002).
  • Porta-Etessam J, Benito-Leon J, Martinez-Salio A, Berbel A. Gabapentin in the treatment of SUNCT syndrome. Headache42(6), 523–524 (2002).
  • Matharu MS, Boes CJ, Goadsby PJ. SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology58(8), 1307 (2002).
  • Matharu MS, Cohen AS, Goadsby PJ. SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia24(11), 985–992 (2004).
  • Schwaag S, Frese A, Husstedt IW, Evers S. SUNCT syndrome: the first German case series. Cephalalgia23(5), 398–400 (2003).
  • Ferrari A, Sternieri E, Ferraris E, Bertolini A. Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis. Pharmacol. Res.48(1), 1–9 (2003).
  • Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Neurology67(1), 109–113 (2006).
  • Leone M, Franzini A, D’Andrea G, Broggi G, Casucci G, Bussone G. Deep brain stimulation to relieve drug-resistant SUNCT. Ann. Neurol.57(6), 924–927 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.